EUR-Lex Search results

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Search Results

Domain: All, Subdomain: EFTA documents, Author: Standing Committee of the EFTA States, Search language: English
2

Recommendation by the Standing Committee of the EFTA States No 1/2020/SC on the notification by Norway from 5 November 2020 of the use of a Systemic Risk Buffer according to Article 133 of Directive 2013/36/EU on access to the activity of credit institutions and prudential supervision of credit institutions and investment firms, as incorporated into the EEA Agreement by Decision of the EEA Joint Committee No 79/2019 2021/C 65/06

CELEX number:
E2020G0001
Author:
Standing Committee of the EFTA States
Date of document:
25/02/2021; Date of publication

Medicinal products – List of marketing authorisations granted by the EEA EFTA States for the first half of 2020 2021/C 39/04 Subcommittee I on the free movement of goods To be noted by the EEA Joint Committee

CELEX number:
E2021G0204(02)
Author:
Standing Committee of the EFTA States
Date of document:
04/02/2021; Date of publication

Dangerous substances – List of authorisation decisions taken by the EEA EFTA States in accordance with Article 64(8) of Regulation (EC) No 1907/2006 (REACH) in the first half of 2020 2021/C 39/03 Subcommittee I on the free movement of goods To be noted by the EEA Joint Committee

CELEX number:
E2021G0204(01)
Author:
Standing Committee of the EFTA States
Date of document:
04/02/2021; Date of publication

Dangerous substances – List of authorisation decisions taken by the EEA EFTA States in accordance with Article 64(8) of Regulation (EC) 1907/2006 (REACH) in the second half of 2019 2020/C 308/05 Subcommittee I on the free movement of goods To be noted by the EEA Joint Committee

CELEX number:
E2020G0917(02)
Author:
Standing Committee of the EFTA States
Date of document:
17/09/2020; Date of publication

Dangerous substances — List of authorisation decisions taken by the EEA EFTA States in accordance with Article 44(5) of Regulation (EU) 528/2012 in the second half of 2019 2020/C 308/04 Subcommittee I on the free movement of goods To be noted by the EEA Joint Committee

CELEX number:
E2020G0917(01)
Author:
Standing Committee of the EFTA States
Date of document:
17/09/2020; Date of publication

Medicinal products – List of marketing authorisations granted by the EEA EFTA States for the second half of 2019 2020/C 308/06 Subcommittee I on the free movement of goods To be noted by the EEA Joint Committee

CELEX number:
E2020G0917(03)
Author:
Standing Committee of the EFTA States
Date of document:
17/09/2020; Date of publication

Dangerous substances – List of authorisation decisions taken by the EEA EFTA States in accordance with Article 64(8) of Regulation (EC) No 1907/2006 (REACH) in the second half of 2018 2020/C 123/09

CELEX number:
E2020G0416(04)
Author:
Standing Committee of the EFTA States
Date of document:
16/04/2020; Date of publication

Medicinal products – List of marketing authorisations granted by the EEA EFTA States for the second half of 2018 2020/C 123/06

CELEX number:
E2020G0416(01)
Author:
Standing Committee of the EFTA States
Date of document:
16/04/2020; Date of publication

Medicinal products – List of marketing authorisations granted by the EEA EFTA States for the first half of 2019 2020/C 123/07

CELEX number:
E2020G0416(02)
Author:
Standing Committee of the EFTA States
Date of document:
16/04/2020; Date of publication

Dangerous substances — List of authorisation decisions taken by the EEA EFTA States in accordance with Article 64(8) of Regulation (EC) No 1907/2006 (REACH) in the first half of 2018 2020/C 123/08

CELEX number:
E2020G0416(03)
Author:
Standing Committee of the EFTA States
Date of document:
16/04/2020; Date of publication
2